reported a fourfold increase in residual gastric content, with 4/49 patients on GLP-1 agonists compared to 2/188 in the control group [31]
The staff was knowledgeable and helpful
David Rosenblum, MD, currently serves as the director of pain management at Maimonides Medical Center and managing partner of the multi-physician private pain practice, AABP Integrative Pain Care, both in Brooklyn, New York
MahmoudianDehkordi S, Ahmed AT, Bhattacharyya S, Han X, Baillie RA, Arnold M, et al
Burning after semaglutide injection is a common local reaction experienced by some patients using this GLP-1 receptor agonist for type 2 diabetes or chronic weight management
Protected storage supports reliable safe medication mixing practices